Closed Loop Medicine Raises £2.1M in Pre-Series A Funding

Closed Loop Medicine, a Cambridge and London-based health tech startup, has raised £2.1 million in Pre-Series A funding from Longwall Venture Partners, IQ Capital, Martlet, and Cambridge Angel investors. The company, founded in 2017, combines proven drug treatments with digital therapeutics to tailor drug and non-drug therapy based on patient responses. The funding will be used to develop a drug + digital approach to treat and manage major health conditions, starting with sleep disturbance and hypertension. Closed Loop Medicine intends to develop fully regulated, evidence-based Drug + Digital solutions for the NHS and international healthcare providers.

Closed Loop Medicine Secures £2.1 Million for Drug + Digital Therapeutics

Closed Loop Medicine is a therapeutics company that combines proven drug treatments with digital therapeutics. Digital therapeutics deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. The company’s approach uses data and insights about how a patient is responding to treatment to tailor drug and non-drug therapy.

A therapeutics company combining proven drug treatments with digital therapeutics to tailor drug and non-drug therapy.

6 years ago

Closed Loop Medicine Secures £2.1 Million for Drug + Digital Therapeutics

ProblemHealthcare

Solution

Covered on